Yongjun Li
Impact in
- Microbiology top 5%
- Infectious Diseases top 5%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Protein Kinase Regulation and GTPase Signaling 3
- Melanoma and MAPK Pathways 2
- Circular RNAs in diseases 2
-
- Cardiac Fibrosis and Remodeling 4
- Cardiovascular Function and Risk Factors 3
- Viral Infections and Immunology Research 2
- Co-authors
- Yumeng Yao (1 shared paper)Chun Li (1 shared paper)Chunmei Zhou (1 shared paper)Mengran Wang (1 shared paper)Bing Li (1 shared paper)Maosong Ye (1 shared paper)Jue Pan (1 shared paper)Wenting Jin (1 shared paper)
- Journals
- Diabetes/Metabolism Research and Reviews (2 papers)Clinical Infectious Diseases (1 paper)Journal of Pharmacological Sciences (1 paper)Cellular Physiology and Biochemistry (1 paper)Journal of Cardiovascular Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yongjun Li
41 papers receiving 1.4k citations
Yongjun Li's Hit Papers
Peers
Comparison fields: 5 of 114
- Microbiology 30
- Infectious Diseases 331
- Clinical Biochemistry 117
- Epidemiology 528
- Molecular Medicine 56
Countries citing papers authored by Yongjun Li
This map shows the geographic impact of Yongjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjun Li more than expected).
Fields of papers citing papers by Yongjun Li
This network shows the impact of papers produced by Yongjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjun Li. The network helps show where Yongjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yongjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice Hit paper breakdown → | 2018 | 602 |
| 2 | 2020 | 162 | |
| 3 | 2011 | 77 | |
| 4 | 2012 | 61 | |
| 5 | 2007 | 48 | |
| 6 | 2016 | 44 | |
| 7 | 2018 | 43 | |
| 8 | 2009 | 41 | |
| 9 | 2018 | 39 | |
| 10 | 2011 | 31 | |
| 11 | 2015 | 30 | |
| 12 | 2014 | 25 | |
| 13 | 2015 | 25 | |
| 14 | 2018 | 23 | |
| 15 | 2021 | 21 | |
| 16 | 2020 | 21 | |
| 17 | 2008 | 20 | |
| 18 | 2010 | 13 | |
| 19 | 2020 | 13 | |
| 20 | 2011 | 12 |
About Yongjun Li
Yongjun Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery, Rheumatology and Complementary and alternative medicine, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Cardiovascular Function and Risk Factors (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Folate and B Vitamins Research (3 papers), Melanoma and MAPK Pathways (2 papers), Viral Infections and Immunology Research (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Microbiology (30 citations), Infectious Diseases (331 citations), Clinical Biochemistry (117 citations), Epidemiology (528 citations) and Molecular Medicine (56 citations). Yongjun Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yumeng Yao, Chun Li, Chunmei Zhou, Mengran Wang, Bing Li, Maosong Ye, Jue Pan, Wenting Jin, Xiaoling Xu and Yuyan Ma. Their work appears in journals such as Diabetes/Metabolism Research and Reviews, Clinical Infectious Diseases, Journal of Pharmacological Sciences, Cellular Physiology and Biochemistry and Journal of Cardiovascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.